No longer trading

Delisted

The delisting was filed on March 2, 2026 (SEC Form 15-12G). Its last closing price was on March 20, 2026. It has left the AI-ranked universe. The score and rank below are its final ones, from March 2, 2026. Source: SEC Form 15-12G

SSKN

STRATA Skin Sciences, Inc. SSKN

NasdaqSmall CapHealthcare

Final 13F Pro quality score

Final rank #2,588 of 2,753 · as of March 2, 2026

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$9.29M

Quarter to Dec 31

Net income

$58.0K

Quarter to Dec 31

Free cash flow

$-551.0K

Quarter to Dec 31

Operating margin

5.3%

Quarter to Dec 31

Top Institutional Holders

as of Q4 2025
$1.37M total
Reading the latest SEC filing…

Key Metrics

Revenue

Q4 2025
EDGAR

Net Income

Q4 2025
EDGAR

EPS (Diluted)

Q4 2025
EDGAR

Operating Margin

Q4 2025
EDGAR

ROIC

Q4 2025
EDGAR

Free Cash Flow

Q4 2025
EDGAR

Debt/Equity

Q4 2025
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/SSKN

Earnings Per Share

13fpro.ai/company/SSKN

Loading ratio trend…

SSKN key financials by period

Reported revenue, net income and operating margin by fiscal year, from STRATA Skin Sciences, Inc.'s annual filings on SEC EDGAR.

STRATA Skin Sciences, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$30.7M$-6.3M-15.3%
FY 2024$33.6M$-10.1M-27.6%
FY 2023$33.4M$-10.8M-25.8%
FY 2022$36.2M$-5.5M-12.9%
FY 2021$30.0M$-2.7M-14.7%
FY 2020$23.1M$-4.4M-17.6%
Source: SSKN filings on SEC EDGAR →

About STRATA Skin Sciences, Inc. (SSKN): stock profile, AI score and financials

Delisted: STRATA Skin Sciences, Inc. (SSKN) no longer trades and has left 13F Pro's AI-ranked universe. The delisting was filed on March 2, 2026 (SEC Form 15-12G). Its last closing price was on March 20, 2026. It has left the AI-ranked universe. The score and rank below are its final ones, from March 2, 2026. STRATA Skin Sciences, Inc. (SSKN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro tracks SSKN using direct SEC EDGAR data and AI-powered research tools. Based on the latest XBRL financial filings (Q4 2025), STRATA Skin Sciences, Inc. reports quarterly revenue of $9.3M, net income of $58.0K, an operating margin of 5.3%. SSKN trades on the Nasdaq exchange and files with the SEC under CIK 1051514. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SSKN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for STRATA Skin Sciences, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1051514 →